Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000210627 | SCV000262912 | uncertain significance | Inborn genetic diseases | 2013-07-18 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Center for Pediatric Genomic Medicine, |
RCV000442384 | SCV000511625 | likely benign | not provided | 2016-11-30 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001082743 | SCV000641822 | benign | Vici syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000442384 | SCV000692936 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | EPG5: BP4, BS2 |
Gene |
RCV000442384 | SCV001841185 | benign | not provided | 2020-10-02 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001573112 | SCV001798485 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000442384 | SCV001967159 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003917859 | SCV004731720 | benign | EPG5-related disorder | 2024-01-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |